4.6 Article

Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

期刊

GYNECOLOGIC ONCOLOGY
卷 158, 期 2, 页码 316-322

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ygyno.2020.05.002

关键词

Ovarian cancer; Symptoms; Routes to diagnosis; Survival; UKCTOCS; GOFF index; NICE

资金

  1. National Institute for Health Research (NIHR) HTA grant [16/46/01]
  2. Eve Appeal
  3. Medical Research Council [G9901012, G0801228]
  4. Cancer Research UK [C1479/A2884]
  5. Department of Health, Australia
  6. NIHR University College London Hospitals BRC
  7. MRC [MR_UU_12023]
  8. MRC [MC_UU_12023/28, G0801228, G0000735, G9901012] Funding Source: UKRI

向作者/读者索取更多资源

Objective. There are widespread efforts to increase symptom awareness of 'pelvic/abdominal pain, increased abdominal size/bloating, difficulty eating/feeling full and urinary frequency/urgency' in an attempt to diagnose ovarian cancer earlier. Long-term survival of women with these symptoms adjusted for known prognostic factors is yet to be determined. This study explored the association of symptoms, routes and interval to diagnosis and long-term survival in a population-based cohort of postmenopausal women diagnosed with invasive epithelial tubo-ovarian cancer (iE0C) in the 'no screen' (control) UKCTOCS arm. Methods. Of 101,299 women in the control arm. 574 were confirmed on outcome review to have iE0C between randomisation (2001-2005) and 31 December 2014. Data was extracted from medical notes and electronic records. A multivariable model was fitted for individual symptoms, time interval from symptom onset to diagnosis, route to diagnosis, speciality, morphological Type, age at diagnosis, year of diagnosis (period effect), stage, primary treatment, and residual disease. Results. Women presenting with symptoms listed in the NICE guidelines (HR1.48, 95%CI 1.16-1.89, p = 0.001) or the modified Goff Index (HR1- 68, 95%CI 1.32-2.13, p < 0.0001) had significantly worse survival than those who did not. Each additional presenting symptom decreased survival (HR1.20, 95%CI 1.12-1.28, p < 0.0001). In multivariable analysis, in addition to advanced stage, increasing residual disease and inadequate primary treatment, abdominal pain and loss of appetite/feeling full were significantly associated with increased mortality. Conclusions. The ovarian cancer symptom indices identify postmenopausal women with a poorer prognosis. This study however cannot exclude the possibility of better outcomes in those who are aware and act on their symptoms. (C) 2020 The Authors. Published by Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据